Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone

Johnsen, Erik; A.^Kroken, Rune; Wentzel-Larsen, Tore; A.^Jørgensen, Hugo
January 2010
BMC Psychiatry;2010, Vol. 10, p26
Academic Journal
Background: No clear recommendations exist regarding which antipsychotic drug should be prescribed first for a patient suffering from psychosis. The primary aims of this naturalistic study were to assess the head-to-head effectiveness of first-line second-generation antipsychotics with regards to time until drug discontinuation, duration of index admission, time until readmission, change of psychopathology scores and tolerability outcomes. Methods: Patients = 18 years of age admitted to the emergency ward for symptoms of psychosis were consecutively randomized to risperidone (n = 53), olanzapine (n = 52), quetiapine (n = 50), or ziprasidone (n = 58), and followed for up to 2 years. Results: A total of 213 patients were included, of which 68% were males. The sample represented a diverse population suffering from psychosis. At admittance the mean Positive and Negative Syndrome Scale (PANSS) total score was 74 points and 44% were antipsychotic drug naïve. The primary intention-to-treat analyses revealed no substantial differences between the drugs regarding the times until discontinuation of initial drug, until discharge from index admission, or until readmission. Quetiapine was superior to risperidone and olanzapine in reducing the PANSS total score and the positive subscore. Quetiapine was superior to the other drugs in decreasing the PANSS general psychopathology subscore; in decreasing the Clinical Global Impression - Severity of Illness scale score (CGI-S); and in increasing the Global Assessment of Functioning - Split version, Functions scale score (GAF-F). Ziprasidone was superior to risperidone in decreasing the PANSS positive symptoms subscore and the CGI-S score, and in increasing the GAF-F score. The drugs performed equally with regards to most tolerability outcomes except a higher increase of hip-circumference per day for olanzapine compared to risperidone, and more galactorrhoea for risperidone compared to the other groups. Conclusions: Quetiapine appears to be a good starting drug candidate in this sample of patients admitted to hospital for symptoms of psychosis. Trial Registration: ClinicalTrials.gov ID; URL: http://www.clinicaltrials.gov/: NCT00932529.


Related Articles

  • Choking deaths: the role of antipsychotic medication. Ruschena, D.; Mullen, P. E.; Palmer, S.; Burgess, P.; Cordner, S. M.; Drummer, O. H.; Wallace, C.; Barry-Walsh, J. // British Journal of Psychiatry;Nov2003, Vol. 183, p446 

    Background: An increased risk of choking associated with antipsychotic medication has been repeatedly postulated.Aims: To examine this association in a large number of cases of choking deaths.Method: Cases of individuals who had died because of choking were...

  • Sixteen-year mortality in patients with affective disorder commenced on lithium. Brodersen, A.; Licht, R. W.; Vestergaard, P.; Olesen, A. V.; Mortensen, P. B. // British Journal of Psychiatry;May2000, Vol. 176, p429 

    Background: Lithium treatment is claimed to reduce mortality in patients with affective disorder, but the evidence is conflicting.Aim: To estimate mortality rates from a cohort of patients with affective disorder commenced on lithium with an observation period of two...

  • List of Drugs in Development for Neurodegenerative Diseases. Pogačić, Vanda; Herling, Paul // Neurodegenerative Diseases;2007, Vol. 4 Issue 6, p443 

    Background/Aims: Alzheimer’s disease (AD) is characterized by extracellular Aβ peptide deposition originating from amyloid precursor protein cleavage and intracellular neurofibrillary tangles resulting from pathological tau protein aggregation. These processes are accompanied by...

  • Effects of long-term treatment with antipsychotics on serum leptin levels. Herrán, Andrés; García-Unzueta, María Teresa; Amado, José Antonio; de la Maza, María Teresa; Álvarez, Concepción; Vázquez-Barquero, José Luis; Herrán, A; García-Unzueta, M T; Amado, J A; de La Maza, M T; Alvarez, C; Vázquez-Barquero, J L // British Journal of Psychiatry;Jul2001, Vol. 179, p59 

    Background: Abnormal regulation of the adipocyte-derived hormone leptin could play a role in body weight gain induced by antipsychotics.Aims: To study the effects of long-term antipsychotic treatment on leptin levels in patients with schizophrenia.Method:...

  • Clozapine rechallenge after an episode of 'neuroleptic malignant syndrome'. Weller, Michael; Kornhuber, Johannes; Weller, M; Kornhuber, J // British Journal of Psychiatry;Dec92, Vol. 161, p855 

    Nine out of 4044 patients admitted to our institution between 1987 and 1990 suffered an episode of NMS. Neuroleptic rechallenge using clozapine for persisting psychiatric illness was tolerated by eight patients. Clozapine was discontinued in one older, high-risk patient because recurrence of NMS...

  • Olanzapine and tardive dyskinesia. Woods, S. W. // British Journal of Psychiatry;Oct99, Vol. 175, p391 

    A letter to the editor is presented in response to the article "Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol," by C.M. Beasley and colleagues in volume 174.

  • Involvement of Basal Ganglia Network in Motor Disabilities Induced by Typical Antipsychotics. Chetrit, Jonathan; Ballion, Bérangère; Laquitaine, Steeve; Belujon, Pauline; Morin, Stéphanie; Taupignon, Anne; Bioulac, Bernard; Gross, Christian E.; Benazzouz, Abdelhamid // PLoS ONE;2009, Vol. 4 Issue 7, p1 

    Background: Clinical treatments with typical antipsychotic drugs (APDs) are accompanied by extrapyramidal motor sideeffects (EPS) such as hypokinesia and catalepsy. As little is known about electrophysiological substrates of such motor disturbances, we investigated the effects of a typical APD,...

  • Review: "Warning: Psychiatry Can Be Hazardous To Your Mental Health". Lennon, Brian // International Journal of Reality Therapy;Fall2003, Vol. 23 Issue 1, p15 

    This article reviews Dr. Glasser's latest book "Warning: Psychiatry can be hazardous to your mental health". It outlines his objections to psychiatric medication and the premises on which they are based. Glasser's new emphasis on the promotion of mental health is explained as is his concept of...

  • Correlations between akathisia and residual psychopathology: a by-product of neuroleptic-induced dysphoria. Newcomer, John W.; Miller, L. Stephen; Faustman, William O.; Wetzel, Martin W.; Vogler, George P.; Csernansky, John G.; Newcomer, J W; Miller, L S; Faustman, W O; Wetzel, M W; Vogler, G P; Csernansky, J G // British Journal of Psychiatry;Jun94, Vol. 164, p834 

    Patients developing neuroleptic-induced akathisia have been reported to show higher levels of psychopathology. We sought to replicate this finding and determine its symptom specificity. We confirmed a significant relationship between ratings of akathisia and total score on the Brief Psychiatric...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics